Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
In this study, we will compare the safety and efficacy of 400 mcg sublingually administered
misoprostol alone to standard surgical care for the treatment of incomplete abortion. This
study will provide important data on the role of misoprostol in health services offering an
array of treatments for incomplete abortion. Women could significantly benefit from a
non-invasive treatment option for incomplete abortion. While safe surgical services are
becoming more widespread, there is still a serious risk of complications from these
procedures. Especially in developing countries, infection, hemorrhage and uterine damage are
still too common. Medical treatment of incomplete abortion using misoprostol would be a
tremendous step to reducing morbidity and mortality due to abortion complications.